REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,577,621 | +1281.8% | 273,758 | +1235.4% | 0.00% | – |
| Q2 2023 | $548,375 | +60.0% | 20,500 | +29.6% | 0.00% | – |
| Q1 2023 | $342,726 | -92.2% | 15,823 | -91.4% | 0.00% | -100.0% |
| Q4 2022 | $4,390,955 | +182.0% | 184,339 | +133.5% | 0.00% | – |
| Q3 2022 | $1,557,000 | -59.5% | 78,952 | -59.9% | 0.00% | -100.0% |
| Q2 2022 | $3,841,000 | +125.4% | 197,060 | +195.0% | 0.00% | – |
| Q1 2022 | $1,704,000 | -83.5% | 66,802 | -83.7% | 0.00% | -100.0% |
| Q4 2021 | $10,327,000 | +204.1% | 410,305 | +232.4% | 0.00% | +100.0% |
| Q3 2021 | $3,396,000 | -51.6% | 123,422 | -44.2% | 0.00% | 0.0% |
| Q2 2021 | $7,017,000 | -86.4% | 221,061 | -80.3% | 0.00% | -92.3% |
| Q1 2021 | $51,615,000 | +5.2% | 1,124,992 | -9.3% | 0.01% | 0.0% |
| Q4 2020 | $49,079,000 | +276.6% | 1,239,676 | +231.1% | 0.01% | +225.0% |
| Q3 2020 | $13,031,000 | -2.2% | 374,465 | -11.3% | 0.00% | -20.0% |
| Q2 2020 | $13,321,000 | +74.4% | 421,936 | +21.0% | 0.01% | +66.7% |
| Q1 2020 | $7,638,000 | – | 348,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |